Directory Gematotropona funds Coagulants (including factors such as blood clotting), gemostatiki Koeit-hp
This page is translated automatically with a help of Google Translate

Koeit-hp

See also Antihemophilic factor viii

Roman name

Koate-HP

The composition and the form of

1 bottle with liofilizirovannam powders for the preparation of injection solution contains antigemofilland factor VIII (rights), 250, 500, 1,000 or 1,500 IU; together with the solvent in the sealed to 5 or 10 ml respectively, as well as with bilateral needle, and igla-filtrom set for the injection.

Of drugs

Complementary deficit reduction factor VIII.

Farmakodinamika

Provides increase in the level of factor VIII in the blood plasma and temporarily correct coagulation defect.

Indications

Hemophilia A (the treatment and prevention of bleeding).

Contraindications

None.

Side-Effects

Allergic reactions.

Precautions

It should closely monitor the formula blood in patients with blood group A, B or AB (to detect early signs of anaemia). When pregnancy is used only in cases of extreme necessity.

Dosing and Administration

B / 386/1989 To prevent spontaneous bleeding or light bleeding-10 IU / kg Moderate bleeding and a small surgical intervention is 15-25 IU / kg followed by supporting dose 10-15 IU / kg every 8 to 12 hours In the case of severe bleeding, a life-threatening or involves vital structures, 40-50 IU / kg, followed by maintenance dose of 20 to 25 IU / kg every 8 to 12 hours The large surgical-40-50 IU / kg for 1 h before and the 20 to 25 IU / kg after 5 h after the first dose.

Storage conditions

por.liof.d / in. : List B. The temperature of 2-8 ° C (not freezing). In short storage (up to 6 months), with the temperature up to 25 ° C.

Shelf life

por.liof.d / in. : 2 grams.

All products of this group

0